Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Browse the detailed record of transactions filed by Brown William Michael, Chief Financial Officer. Director active across 1 company, notably Altimmune, Inc.. Aggregated, 2 disclosures have been recorded. Activity tracked since 31 July 2021. The latest transaction was disclosed on 31 July 2021 (Attribution). Regulator: SEC (Form 4). All data is free.
2 of 2 declarations
William Michael Brown is the Chief Financial Officer of Altimmune, Inc. He oversees the company's financial management, including financial planning, risk management, and financial reporting. His expertise in finance is essential to support the company's growth and financial strategy.